by Sue Robbins | Mar 9, 2020 | Migraine
The Food and Drug Administration (FDA) has approved Nurtec™ ODT (rimegepant; Biohaven) for the acute treatment of migraine with or without aura in adults. Nurtec ODT is a calcitonin gene-related peptide receptor antagonist administered via an orally disintegrating...
by Sue Robbins | Jul 2, 2019 | Migraine
Read more here.